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SPOTLIGHT
ISG15 fast-tracks DNA replication
Alice Meroni and Alessandro Vindigni
In this issue, Raso et al. (2020. J. Cell Biol. https://doi.org/10.1083/jcb.202002175) uncover a novel replication fork speed
regulatory network controlled by the ubiquitin-like modifier interferon-stimulated gene 15 (ISG15), which plays a central role in
the innate immune response and regulates tumorigenesis as well as chemotherapy response.
DNA replicates by unzipping its two inter-
woven strands and making copies of each.
As the DNA strands separate and copy, they
form a “replication fork.” The speed at
which replication forks progress along the
DNA must be tightly controlled to ensure
genome stability and faithful duplication of
the genome. In this issue, Raso et al. (1)
uncover a novel replication fork speed reg-
ulatory network controlled by the ubiquitin-
like modifier interferon-stimulated gene 15
(ISG15). They propose that higher expres-
sion of ISG15 induced by interferons or
commonly detected in many types of cancer
cells drives deregulated fork speed, leading
to DNA damage and genome instability.
ISG15 is as ubiquitin-like modifier that
plays a central role in the innate immune
response, which is the first line of host de-
fense against a vast array of pathogens,
including bacteria, fungi, viruses, and
parasites. The innate immune response
promotes the production of interferons
(IFNs) that in turn stimulate the production
of ISG15 (2). ISG15 acts by modifying cellular
proteins in a process called ISGylation con-
sisting on the conjugation of a small-size
polypeptide similar to ubiquitin to target
proteins. The exact function of ISG15 and its
ubiquitin-like activity in the innate immune
response is poorly understood. Interestingly,
ISG15 is highly expressed in many tumor
types, but how its higher expression levels
correlate with tumorigenesis and cancer cell
response to chemotherapeutics remains largely
unexplored.
Raso et al. provide a fresh view into the
function of ISG15 by showing that its higher
expression levels increase replication fork
speed, leading to DNA damage and genomic
instability. The idea that increasing repli-
cation fork speed above a certain threshold
leads to DNA damage and genome instability
is an emerging theme in the replication
field, whereby faster replicating forks have
insufficient time to recognize damaged DNA
in need of repair. This leads to accumulation
of DNA damage and increased cellular sensi-
tivity to DNA damaging agents, as observed by
Raso et al. A central post-translation modifi-
cation for replication speed is poly-(ADP-
ribosyl)ation mediated by the PARP family of
proteins, whose inhibition also leads to faster
replication forks (3). Raso et al. suggest that
PARP inhibitors and ISG15 affect replication
fork speed by similar mechanisms and show
that increasing ISG15 levels significantly en-
hances cancer cell sensitivity to PARP in-
hibitors. PARP inhibitors are used to treat
different tumor types, particularly those car-
rying mutations in key DNA repair genes (4).
The findings of Raso et al. reveal that the
ISG15-dependent increase in fork speed is an
important and previously unappreciated mod-
ulator of cancer cell response to PARP inhibitors
and DNA-damaging chemotherapy.
To uncover the pathway by which ISG15
speeds up replication forks, Raso et al. ran a
mass spectrometry analysis searching for
ISG15-interacting proteins and found a
number of chromatin-associated factors,
some of which were previously reported to
interact with replication forks. Among
these, they focused on the human RECQ1
helicase, a protein that promotes the restart
of stalled replication forks (5). In particular,
RECQ1 promotes restart by facilitating the
resolution of reversed fork structures. Fork
reversal is a mechanism that allows repli-
cation forks to cope with DNA damage en-
countered ahead of their path by reversing
their course (6). The results of Raso et al.
suggest that ISG15 may regulate RECQ1
function by unleashing its reversed fork
restart activity. Interestingly, this mecha-
nism depends on the functional interaction
of ISG15 with the RECQ1 helicase but seems
to be largely independent of ISG15 conju-
gation activity. These findings have several
important implications. First, they point to a
potential and previously unappreciated role
of ISG15 in replication fork reversal, even
though the exact mechanism by which
ISG15 promotes the reversed fork restart
function of RECQ1 remains elusive. Second,
the effect of PARP inhibitors on replication
fork restart also relies on the deregulation of
RECQ1 activity (5), suggesting that ISG15
and PARP inhibitors might affect replication
fork progression by a similar mechanism.
Third, the authors’ findings point to a novel
link between deregulated fork progression
induced by the ISG15-PARP inhibitor-RECQ1
axis, increased DNA damage, and cancer cell
response to chemotherapy. These findings
also suggest that increased RECQ1 activity
caused by high ISG15 levels or PARP inhibi-
tionmight represent an important vulnerability
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to be exploited in cancer treatment. As in-
creased ISG15 levels sensitize cancer cells to
DNA damaging chemotherapeutics and PARP
inhibitors, monitoring ISG15 or RECQ1 levels in
tumor samples may represent a novel predic-
tive parameter to stratify patients in personal-
ized cancer therapy.
The innate immune system operates
under the assumption that no free DNA
should be present in the cytosol and that any
cytosolic DNA linked to bacterial or viral
infection is recognized as nonself (7). Cyto-
solic DNA can be recognized by the cGAS-
STING pathway, which induces type I IFNs
and other cytokine genes (8). Recent studies
demonstrated that, in addition to pathogens,
defects in replication fork processing can
also lead to the accumulation of cytosolic
DNA and transactivate innate immune re-
sponse genes, leading to higher expression
of ISG15 (9). These studies, along with the
findings of Raso et al., suggest that ISG15
might be at the center of a feedback loop
where the increased replication fork speed
linked to higher ISG15 expression leads to
increased replication stress, in turn acti-
vating the innate immune response.
In summary, Raso et al. provide a fresh
view on the function of a central immune
response factor in genome stability and
outline a previously unknown network
influencing replication fork speed (Fig. 1).
Their work opens several new areas of in-
vestigation that will revolutionize current
models of how innate immune response
genes regulate tumorigenesis and chemo-
therapy response, but it also raises several
questions. For example, the authors’ obser-
vation that the ISG15 function in replication
is largely uncoupled from its conjugation
activity begs the question of what might be
the role of this activity in the context of DNA
damage and replication stress. In particular,
the mass spectrometry analysis revealed
several other ISG15 interactors whose
function might be regulated by ISGylation
activity. A key challenge for future studies
will be to understand if ISG15, and its in-
teraction with these protein partners, play
additional roles in genome maintenance
besides the observed regulation of RECQ1’s
fork restart function.
Another area of interest for future re-
search is to explore why cells evolved a
system that is potentially harmful to cell
survival to counteract host infection. Raso
et al. speculate that the detrimental effects
of ISG15 might arise only when its increased
expression is uncoupled from its conjuga-
tion function, but this would need to be
demonstrated. Finally, the findings of Raso
et al. will no doubt prompt many research
groups to study why cancer cells choose to
increase ISG15 expression. How does higher
ISG expression give an advantage to cancer
cell growth? Recent studies suggest that
ISG15 has either oncogenic or tumor-
suppressive effects depending on the con-
text (10), and the findings of Raso et al. will
undoubtedly spark new research to under-
stand the connection between deregulated
fork speed caused by higher ISG15 expres-
sion and tumorigenesis.
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Figure 1. The ISG15-RECQ1 network controls replication fork speed.High levels of ISG15 expression,
which are triggered by the production of interferons and are commonly detected in many human tumors,
stimulate the replication fork start activity of RECQ1, leading to accelerated fork speed and increased
genomic instability.
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